Share:
Japan has long been a tough nut to crack for US and European private equity firms.
Back in 2012, when I began a stint covering Japan s PE market, one of the first deals I reported on was KKR s attempt to buy chipmaker Renesas.
Loathe to see a US buyer take control, an investor group that included the government-backed Innovation Network Corporation of Japan swooped in to buy the loss-making company. At the time, that outcome painted a bleak picture of Japan s buyout market for foreign investors.
Nearly a decade later, deals by KKR and other PE investors represent a sign that recent changes in Japan s corporate landscape are beginning to produce rewards for foreign firms in a market renowned for its limitations.
RNAi
Want a sneak peek into the Oligonucleotide Therapeutics market? Access the “Table of Content” of Oligonucleotide Therapeutics market report! https://www.persistencemarketresearch.com/toc/12787
Oligonucleotide Therapeutics Market: Region-wise Outlook
The presence of the main market leaders, market consolidation and commercialization of new molecules are all contributing towards the dominating position of North America in the oligonucleotides therapeutic market. Miragen Therapeutics, Inc. agreed to merge with Signal Genetics, Inc for an initial investment of USD 40 million. Through this merger both the companies expect to develop micro RNA-targeted oligonucleotide clinical products. New molecule application is also another strategy the market players are using to mark their presence in the oligonucleotide therapeutic market. Biogen recently received FDA approval for a new drug application for nusinersen. If approved, the antisense oligonucleotides molecule would be the f
streetAsia s premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW
Singapore Reporter/s
In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digi
Govt s 5G SPV a potential positive for edotco s Malaysia business, says Axiata theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.